XYTOS Establishes Partnership with DOVE Clinics

CARSON CITY, Nev.--(BUSINESS WIRE)-- XYTOS, Inc. (the "Company") (OTC: XYTS) is very pleased to announce that we have established a partnership with DOVE Clinics based in the UK (www.doveclinic.com). Like XYTOS, DOVE has been working in several areas of Integrated Advanced Medical Procedures along with Conventional Medicine. In our December 7th 2010 News Release XYTOS updated the shareholders and referenced several points including the statement that the company has moved quickly to position itself to start treating patients in the United States with other geographic areas to be announced. In line with that announcement this partnership was established for several reasons; to name a couple. This is the first step in our business model to announce multiple locations globally for the XYTOS technology to be performed. In addition XYTOS will offer our patients additional advanced medical procedures (to be announced). The partnership will allow for a significant increase in revenues for XYTOS because European Patients interested in XYTOS can now be immediately treated in the UK rather than XYTOS losing patients that cannot travel to the States. Note that patients can reach us at [email protected]

The partnership represents a major step forward in XYTOS’ plan to pursue the future in Advanced Medical Procedures globally. As the XYTOS management continues its forward thinking strategy in the area of advanced medicine the significance of this announcement will become more apparent in the coming announcements.

Tim Cook, Chairman and CEO of XYTOS, Inc., commented, “We are truly excited with this partnership, this relationship will allow XYTOS to better assist our European Patients and significantly increase XYTOS revenues by treating Patients in Europe that are unable to travel to the United States. It is a first step in bringing the XYTOS technology to Patients in specific locations around the world (to be announced). Our doctors will train side by side in new Advanced Medical Techniques and the companies will collaborate on New Advanced Medical Procedures.”

XYTOS, working at the forefront of the "Science of Medicine," is a Bio-Medical Technologies Company concentrating on the research, development, and introduction of Next Generation Medicine and Medical Procedures in the areas of Stem Cell Therapies, Tissue Engineering, Cellular Medicine, and Cancer.



CONTACT:

On behalf of the Board of Directors of: XYTOS Inc.
Tim Cook, CEO, 702-421-5206
[email protected]

KEYWORDS:   United Kingdom  United States  Europe  North America  Indiana  Nevada

INDUSTRY KEYWORDS:   Stem Cells  Health  Alternative Medicine  Biotechnology  Hospitals  Oncology  Pharmaceutical  Other Health  Professional Services  Finance  Research  Science

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.